设计,合成,生物和计算选的新型胺基提亚醇衍生物作为潜在的抗炎剂
相关实验视频
Updated: Jun 28, 2025
05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
Naresh Podila1, Naveen Kumar Penddinti2, Mithun Rudrapal1
1Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology & Research, Vadlamudi, Guntur, 522213, Andhra Pradesh, India.
Heliyon
|April 24, 2024
概括
新型基于皮里丁的亚二衍生物 (NTD1-NTD5) 被合成并测试其抗炎活性. 化合物NTD1,NTD2和NTD3显示出显著的疗效,NTD3与迪克洛芬雅相比显示出更高的抗炎功能.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- 炎症是一种复杂的生物反应,与许多疾病有关.
- 开发新型抗炎药物,提高疗效和安全性,这一点至关重要.
- 皮里丁和提亚醇支架是药物发现中的已知药用剂.
研究的目的:
- 为了合成和表征新的基于皮里丁的亚二醇衍生物.
- 评估这些化合物的体内和体内抗炎潜力.
- 确定化合物作为抗炎治疗药物进行进一步开发.
主要方法:
- 合成基于皮里丁的亚二醇衍生物 (NTD1-NTD5).
- 使用FTIR,NMR (H,C) 和质谱的表征.
- 在体内,急性毒性和抗炎性测定.
- 在基中对抗COX-2的分子对接 (PDB ID: 1pxx).
- 分子动力学模拟 (100 ns) 和药物相似性分析 (SwissADME).
主要成果:
- 化合物NTD1,NTD2和NTD3在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性在体内表现出显著的抗炎活性.
- NTD3显示出最高的强度,没有观察到急性毒性.
- 在体研究中,NTD2和NTD3与COX-2的结合亲和力显著,结合能量与迪克洛菲纳克相当或高于.
- 分子动力学模拟证实了通过与COX-2的稳定相互作用,NTD3具有强大的抑制活性.
- 药物相似性分析表明NTD3具有有利的药理动力学特性.
结论:
- 合成的胺基提亚醇衍生物,特别是NTD3,显示出作为新型抗炎药物的巨大潜力.
- 结合的活体和体数据强烈支持这些化合物的抗炎疗效.
- 需要进一步的研究来阐明结构-活性关系和治疗开发的精确作用机制.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
708
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
708
01:26Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
615
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
615
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K